多发性骨髓瘤反应监测中的问题。
Problems monitoring response in multiple myeloma.
作者信息
Collins Conor D
机构信息
St Vincent's University Hospital, Dublin, Ireland.
出版信息
Cancer Imaging. 2005 Nov 23;5 Spec No A(Spec No A):S119-26. doi: 10.1102/1470-7330.2005.0033.
Abstract
There has been a revolution in the treatment of multiple myeloma over the past decade. This article seeks to correlate advances in imaging with advances in treatment and to highlight how proper understanding of both is necessary for optimum management.
摘要
在过去十年中，多发性骨髓瘤的治疗发生了一场变革。本文旨在将影像学进展与治疗进展相关联，并强调对两者的正确理解对于最佳管理是必要的。
相似文献
1
Problems monitoring response in multiple myeloma.多发性骨髓瘤反应监测中的问题。
Cancer Imaging. 2005 Nov 23;5 Spec No A(Spec No A):S119-26. doi: 10.1102/1470-7330.2005.0033.
2
Multiple myeloma and diagnostic imaging.多发性骨髓瘤与诊断性影像学
Radiol Technol. 2014 Mar-Apr;85(4):391-410; quiz 411-3.
3
Multiple myeloma.多发性骨髓瘤
Radiol Technol. 2005 May-Jun;76(5):379-88; quiz 389-91.
4
Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop.多发性骨髓瘤管理的最新进展：基于资源分层的临床影响。亚洲骨髓瘤网络在第16届国际骨髓瘤研讨会的共识声明。
Leuk Lymphoma. 2018 Oct;59(10):2305-2317. doi: 10.1080/10428194.2018.1427858. Epub 2018 Feb 2.
5
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.多发性骨髓瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2013 Oct;24 Suppl 6:vi133-7. doi: 10.1093/annonc/mdt297. Epub 2013 Aug 16.
6
Multiple myeloma.多发性骨髓瘤。
Cancer Imaging. 2010 Feb 11;10(1):20-31. doi: 10.1102/1470-7330.2010.0013.
7
The Critical Role of Imaging in the Management of Multiple Myeloma.影像学在多发性骨髓瘤管理中的关键作用
Curr Hematol Malig Rep. 2017 Jun;12(3):168-175. doi: 10.1007/s11899-017-0379-9.
8
[The guidelines for the diagnosis and management of multiple myeloma in China (2015 revision) : interpretation of the treatment of relapsing and refractory multiple myeloma].中国多发性骨髓瘤诊断与治疗指南（2015年修订版）：复发/难治性多发性骨髓瘤治疗解读
Zhonghua Nei Ke Za Zhi. 2016 Feb;55(2):93-4. doi: 10.3760/cma.j.issn.0578-1426.2016.02.004.
9
[Multiple Myeloma - Current Status in Diagnostic Testing and Therapy].[多发性骨髓瘤——诊断检测与治疗的现状]
Z Orthop Unfall. 2017 Oct;155(5):575-586. doi: 10.1055/s-0043-110224. Epub 2017 Aug 14.
10
The multiple oral presentations of multiple myeloma.多发性骨髓瘤的多种口服制剂。
Support Care Cancer. 2014 Jan;22(1):259-67. doi: 10.1007/s00520-013-1960-y. Epub 2013 Sep 20.
引用本文的文献
1
Molecular Imaging in Multiple Myeloma-Novel PET Radiotracers Improve Patient Management and Guide Therapy.多发性骨髓瘤中的分子成像——新型PET放射性示踪剂改善患者管理并指导治疗。
Front Nucl Med. 2022 Feb 25;2:801792. doi: 10.3389/fnume.2022.801792. eCollection 2022.
2
Imaging for Plasma Cell Dyscrasias: What, When, and How?浆细胞异常增殖性疾病的影像学检查：检查什么、何时检查以及如何检查？
Front Oncol. 2022 Mar 24;12:825394. doi: 10.3389/fonc.2022.825394. eCollection 2022.
3
Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma.合理靶向Cdc42可克服多发性骨髓瘤的耐药性。
Front Oncol. 2019 Oct 1;9:958. doi: 10.3389/fonc.2019.00958. eCollection 2019.
4
Special considerations for the treatment of multiple myeloma according to advanced age, comorbidities, frailty and organ dysfunction.根据年龄较大、合并症、虚弱和器官功能障碍对多发性骨髓瘤进行治疗的特殊考虑。
Crit Rev Oncol Hematol. 2019 May;137:18-26. doi: 10.1016/j.critrevonc.2019.02.011. Epub 2019 Feb 27.
5
Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on Ga-Pentixafor PET/CT Imaging Using Deep Learning Methods.基于深度学习方法的 Ga- 培门冬酶 PET/CT 成像在多发性骨髓瘤全身骨病灶检测中的应用
Contrast Media Mol Imaging. 2018 Jan 8;2018:2391925. doi: 10.1155/2018/2391925. eCollection 2018.
6
7
Cancerous Inhibitor of PP2A Silencing Inhibits Proliferation and Promotes Apoptosis in Human Multiple Myeloma Cells.蛋白磷酸酶2A沉默的癌性抑制剂抑制人多发性骨髓瘤细胞的增殖并促进其凋亡。
Biomed Res Int. 2016;2016:6864135. doi: 10.1155/2016/6864135. Epub 2016 Apr 6.
8
Treatment-related symptom management in patients with multiple myeloma: a review.多发性骨髓瘤患者的治疗相关症状管理：综述
Support Care Cancer. 2015 May;23(5):1431-45. doi: 10.1007/s00520-014-2552-1. Epub 2015 Feb 3.
9
The Association of HLA Class 1 and Class 2 Antigens with Multiple Myeloma in Iranian Patients.伊朗患者中HLA Ⅰ类和Ⅱ类抗原与多发性骨髓瘤的关联
Turk J Haematol. 2014 Dec 5;31(4):388-93. doi: 10.4274/tjh.2013.0098.
10
The intricate role of CXCR4 in cancer.CXCR4在癌症中的复杂作用。
Adv Cancer Res. 2014;124:31-82. doi: 10.1016/B978-0-12-411638-2.00002-1.
本文引用的文献
1
Multiple myeloma.多发性骨髓瘤
Cancer Imaging. 2004 Jan 14;4 Spec No A(Spec No A):S47-53. doi: 10.1102/1470-7330.2004.0010.
2
Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography.全身低剂量多层螺旋CT在多发性骨髓瘤诊断中的应用：传统X线摄影的替代方法
Eur J Radiol. 2005 May;54(2):289-97. doi: 10.1016/j.ejrad.2004.04.015.
3
International staging system for multiple myeloma.多发性骨髓瘤国际分期系统
J Clin Oncol. 2005 May 20;23(15):3412-20. doi: 10.1200/JCO.2005.04.242. Epub 2005 Apr 4.
4
Side effects and good effects from new chemotherapeutic agents. Case 2. Thalidomide-induced interstitial pneumonitis.
J Clin Oncol. 2005 Apr 1;23(10):2425-6. doi: 10.1200/JCO.2005.04.054.
5
Value of FDG PET in the assessment of patients with multiple myeloma.氟代脱氧葡萄糖正电子发射断层扫描（FDG PET）在多发性骨髓瘤患者评估中的价值。
AJR Am J Roentgenol. 2005 Apr;184(4):1199-204. doi: 10.2214/ajr.184.4.01841199.
6
Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma.一名多发性骨髓瘤患者接受唑来膦酸治疗后发生颌骨骨坏死。
Br J Haematol. 2005 Mar;128(6):738. doi: 10.1111/j.1365-2141.2005.05382.x.
7
Toxicity in standard melphalan-prednisone therapy among myeloma patients with renal failure--a retrospective analysis and recommendations for dose adjustment.肾衰竭骨髓瘤患者标准美法仑-泼尼松疗法的毒性——一项回顾性分析及剂量调整建议
Br J Haematol. 2005 Mar;128(5):631-5. doi: 10.1111/j.1365-2141.2005.05366.x.
8
Evolving treatment strategies for myeloma.骨髓瘤不断演进的治疗策略
Br J Cancer. 2005 Jan 31;92(2):217-21. doi: 10.1038/sj.bjc.6602341.
9
Technetium 99m sestamibi in multiple myeloma.锝99m甲氧基异丁基异腈在多发性骨髓瘤中的应用
Radiology. 2005 Jan;234(1):312-3; author reply 313. doi: 10.1148/radiol.2341040991.
10
Multiple myeloma.多发性骨髓瘤
Hematology Am Soc Hematol Educ Program. 2004:237-56. doi: 10.1182/asheducation-2004.1.237.
Zotero 插件